Draft Guidance for Industry, Clinical Investigators, Institutional Review Boards, and Staff; Availability: Decisions for Investigational Device Exemption Clinical Investigations
Document ID: FDA-2011-D-0790-0004
Comments
Total: 13
-
David Forster - Comment
Posted : 02/28/2012 ID :FDA-2011-D-0790-0005 Agency : FDA -
Mar 09,2012 11:59 PM ET
-
Consortium of Independent Review Boards (CIRB) - Comment
Posted : 02/28/2012 ID :FDA-2011-D-0790-0006 Agency : FDA -
Mar 09,2012 11:59 PM ET
-
Cook Group, Inc. - Comment
Posted : 03/14/2012 ID :FDA-2011-D-0790-0007 Agency : FDA -
Mar 09,2012 11:59 PM ET
-
Johnson and Johnson - Comment
Posted : 03/14/2012 ID :FDA-2011-D-0790-0008 Agency : FDA -
Mar 09,2012 11:59 PM ET
-
AstraZeneca - Comment
Posted : 03/14/2012 ID :FDA-2011-D-0790-0009 Agency : FDA -
Mar 09,2012 11:59 PM ET
-
RTI Biologics, Inc - Comment
Posted : 03/14/2012 ID :FDA-2011-D-0790-0010 Agency : FDA -
Mar 09,2012 11:59 PM ET
-
C. R. Bard, Inc. - Comment
Posted : 03/14/2012 ID :FDA-2011-D-0790-0011 Agency : FDA -
Mar 09,2012 11:59 PM ET
-
Medical Imaging & Technology Alliance (MITA) - Comment
Posted : 03/14/2012 ID :FDA-2011-D-0790-0012 Agency : FDA -
Mar 09,2012 11:59 PM ET
-
Merck & Co., Inc. - Comment
Posted : 03/14/2012 ID :FDA-2011-D-0790-0013 Agency : FDA -
Mar 09,2012 11:59 PM ET
-
Association of Clinical Research Professionals (ACRP) - Comment
Posted : 03/14/2012 ID :FDA-2011-D-0790-0014 Agency : FDA -
Mar 09,2012 11:59 PM ET
-
Abbott - Comment
Posted : 03/14/2012 ID :FDA-2011-D-0790-0015 Agency : FDA -
Mar 09,2012 11:59 PM ET
-
The Procter & Gamble Company - Comment
Posted : 03/14/2012 ID :FDA-2011-D-0790-0016 Agency : FDA -
Mar 09,2012 11:59 PM ET
-
Advanced Medical Technology Association (AdvaMed) - Comment
Posted : 03/14/2012 ID :FDA-2011-D-0790-0017 Agency : FDA -
Mar 09,2012 11:59 PM ET